Literature DB >> 10637555

Interferon beta in multiple sclerosis: is IL-12 suppression the key?

C L Karp1, C A Biron, D N Irani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10637555     DOI： 10.1016/s0167-5699(99)01541-8

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  16 in total

Review 1.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

2.  Interferon beta1a treatment modulates TH1 expression in gammadelta + T cells from relapsing-remitting multiple sclerosis patients.

Authors:  C L Elliott; S Y El-Touny; M L Filipi; K M Healey; M P Leuschen
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

3.  Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo.

Authors:  M Pilar Gil; Rachelle Salomon; Jennifer Louten; Christine A Biron
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113

4.  Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10.

Authors:  Y M Huang; N Stoyanova; Y P Jin; N Teleshova; Y Hussien; B G Xiao; S Fredrikson; H Link
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 5.  Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol).

Authors:  Karim Makhlouf; Howard L Weiner; Samia J Khoury
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects.

Authors:  M C González-Oria; M Márquez-Coello; J A Girón-Ortega; J Argente; M Moya; José-Antonio Girón-González
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-16       Impact factor: 4.147

7.  IRF7-dependent IFN-β production in response to RANKL promotes medullary thymic epithelial cell development.

Authors:  Dennis C Otero; Darren P Baker; Michael David
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

8.  Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12.

Authors:  Burkhard Becher; Brigit G Durell; Randolph J Noelle
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Gene expression studies in multiple sclerosis.

Authors:  Lotti Tajouri; Francesca Fernandez; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2007-05       Impact factor: 2.236

10.  Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor.

Authors:  Jianghuai Liu; Wei-Chun HuangFu; K G Suresh Kumar; Juan Qian; James P Casey; Robert B Hamanaka; Christina Grigoriadou; Rafael Aldabe; J Alan Diehl; Serge Y Fuchs
Journal:  Cell Host Microbe       Date:  2009-01-22       Impact factor: 21.023
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.